Form 4: GE HealthCare Director Catherine Lesjak Receives RSU Grant

Director Catherine Lesjak was granted 3,586 restricted stock units as part of GE HealthCare Technologies Inc. compensation.

Summary

• Director Catherine Lesjak acquired 3,586 restricted stock units (RSUs) on May 7, 2026.
• Each RSU represents the right to receive one share of GE HealthCare common stock.
• The units vest on the earlier of the next annual meeting of stockholders or May 7, 2027.
• Following this transaction, the director's total beneficial ownership is 12,702 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The RSUs are scheduled to vest on the earlier of the next annual meeting of stockholders or May 7, 2027.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure long-term alignment with shareholder value in the medical technology sector.

Comparison to Industry Standards

• The grant of RSUs to directors is consistent with standard compensation practices for S&P 500 and large-cap healthcare companies.
• The vesting schedule aligns with typical one-year cliff vesting cycles for non-employee director equity awards.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation award.

Next Steps

• Vesting of the 3,586 RSUs on the earlier of the next annual meeting or May 7, 2027.

Key Dates

Keywords

GE HealthCare, GEHC, Form 4, Insider Trading, Director Compensation, Restricted Stock Units